Physician profile
Thomas C Truelson
NPI 1780670810
$1,779.39
in general payments reported to CMS, 2019-2025
26 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $178 · 2022: $135 · 2023: $35.89 · 2024: $474 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $299.83 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $198.38 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $178.83 | 2019-2025 | |
| Olympus America INC. | $139.37 | 2020-2025 | Itind System |
| Janssen Biotech, INC. | $113.14 | 2024 | Akeega, Erleada |
| Coloplast Corp | $109.80 | 2022-2025 | Luja Coude |
| Valencia Technologies Corporation | $95.97 | 2025 | Ecoin Device Kit |
| Immunitybio, INC. | $82.55 | 2025 | |
| Boston Scientific Corporation | $78.57 | 2019-2024 | Lithovue |
| Genzyme Corporation | $78.37 | 2019 | |
| Urogen Pharma, INC. | $49.79 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $39.03 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Cook Medical LLC | $28.91 | 2024 | Resonance |
| 180 Medical, INC. | $27.75 | 2024 | Gentlecath Glide |
| Ferring Pharmaceuticals INC. | $26.87 | 2025 | Adstiladrin |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $25.29 | 2019 | |
| Photocure INC | $24.69 | 2024 | Cysview |
| Argon Medical Devices, INC. | $24.52 | 2024 | Clot Management |
| Allergan, INC. | $23.85 | 2022 | |
| Azurity Pharmaceuticals, INC. | $22.23 | 2025 | Azmiro |
| Sumitomo Pharma America, INC. | $21.49 | 2024 | Orgovyx |
| Histosonics, INC. | $20.33 | 2024 | |
| Civco Medical Instruments | $19.27 | 2025 | |
| Endo Pharmaceuticals INC. | $17.66 | 2022 | |
| Bluewind Medical | $17.64 | 2025 | Revi |
| Neotract INC. | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Truelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.